Mcintyre Freedman & Flynn Investment Advisers Inc Novartis Ag Transaction History
Mcintyre Freedman & Flynn Investment Advisers Inc
- $138 Billion
- Q1 2024
A detailed history of Mcintyre Freedman & Flynn Investment Advisers Inc transactions in Novartis Ag stock. As of the latest transaction made, Mcintyre Freedman & Flynn Investment Advisers Inc holds 28,130 shares of NVS stock, worth $2.99 Million. This represents 1.98% of its overall portfolio holdings.
Number of Shares
28,130
Previous 28,330
0.71%
Holding current value
$2.99 Million
Previous $2.86 Billion
4.88%
% of portfolio
1.98%
Previous 2.29%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,346Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.32 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.31 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$773 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$641 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$630 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $229B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...